Hui Kang
- Molecular Biology
- Genetics
- Pulmonary and Respiratory Medicine
- Oncology
- Public Health, Environmental and Occupational Health
- Co-authors
- Calvin Wai-Loon HoYann JolyJonathan IvesRichard HuxtableHub ZwartSo Yoon KimLeonardo D. de CastroYoshihiro Kato
- Topics
- RNA modifications and cancer (2 papers)Intellectual Property and Patents (1 paper)Biomedical Ethics and Regulation (1 paper)
- Cited by
- GeneticsPhysiologyCancer Research
- Partner nations
- ChinaSouth KoreaPhilippines
In The Last Decade
Hui Kang
5 papers receiving 39 citations
Peers
Comparison fields: 5 of 26
- Molecular Biology 19
- Genetics 15
- Pulmonary and Respiratory Medicine 9
- Oncology 8
- Public Health, Environmental and Occupational Health 8
Countries citing papers authored by Hui Kang
This map shows the geographic impact of Hui Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Kang more than expected).
Fields of papers citing papers by Hui Kang
This network shows the impact of papers produced by Hui Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Kang. The network helps show where Hui Kang may publish in the future.
Co-authorship network of co-authors of Hui Kang
This figure shows the co-authorship network connecting the top 25 collaborators of Hui Kang. A scholar is included among the top collaborators of Hui Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hui Kang. Hui Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 24 | |
| 3 | 0 | |
| 4 | 9 | |
| 5 | 1 | |
| 6 | Characterization of immune cells and perforin mutations in familiar venous thromboembolism. | 1 |
About Hui Kang
Hui Kang is a scholar working on Internal Medicine, Parasitology and Management of Technology and Innovation, having authored 6 papers that have together received 39 indexed citations. Recurring topics across this work include RNA modifications and cancer (2 papers), Intellectual Property and Patents (1 paper) and Biomedical Ethics and Regulation (1 paper). The work is most often cited by research in Genetics (15 citations), Physiology (2 citations) and Cancer Research (5 citations). Hui Kang has collaborated with scholars based in China, South Korea and Philippines. Frequent co-authors include Calvin Wai-Loon Ho, Yann Joly, Jonathan Ives, Richard Huxtable, Hub Zwart, So Yoon Kim, Leonardo D. de Castro, Yoshihiro Kato, Yan Cheng and Daniel Stetson. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology and Journal of Clinical Laboratory Analysis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.